Contact Us

Biomarker Testing Market Outlook 2025: Detailed Trends, Size & Share Analysis

18 Aug, 2025

The Biomarker Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Biomarker Testing Market?

The biomarker testing market has seen significant growth recently. The market size is projected to increase from $17.51 billion in 2024 to $19.75 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.8%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Biomarker Testing Industry?

The Biomarker Testing Global Market is forecasted to expand to a size of $31.63 billion in 2029 with a compound annual growth rate (CAGR) of 12.5%.

Download Your Free Sample of the 2025 Biomarker Testing Market Report and Uncover Key Trends Now!

Global Market Segmentation: Identifying Major Biomarker Testing Industry Segments

The biomarker testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments, Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies
3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

What are the Key Growth Drivers Fueling the Biomarker Testing Market?

The key drivers in the biomarker testing marketare:

• Growing application of biomarkers in non-oncology diseases
• Rising investment in companion diagnostics
• Increasing integration of artificial intelligence in diagnostics
• Expanding use of point-of-care testing and rising awareness of preventive healthcare

Pre-order the 2025 Biomarker Testing Global Market Report for Fast Delivery & Comprehensive Insights!

What are the Emerging Trends Shaping the Future of the Biomarker Testing Market?

The key trends in the biomarker testing market are:

• Emerging trends focus on the application of biomarkers in a swath of non-oncology diseases.
• Integration of artificial intelligence in diagnostics is becoming a notable trend.
• The use of point-of-care testing is expanding and gaining attention.
• Increased awareness and implementation of preventive healthcare is influencing the market direction.

Who Are the Top Competitors & Leading Players in the Biomarker Testing Market?

Major companies in the biomarker testing market are:

• Roche Diagnostics International Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Merck KGaA
• Siemens Healthineers AG
• Becton Dickinson and Company
• GE HealthCare Technologies Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• Hologic Inc.
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Myriad Genetics Inc.
• Guardant Health Inc.
• Sino Biological Inc.
• Proteome Sciences plc

Regional Dominance: Which Area Leads the Global Biomarker Testing Market?

North America was the largest region in the biomarker testing market in 2024

Back to top WhatsApp icon